Cooper Companies | Ativo Circulante



Current Assets Alterar Data
Abbott USD 23.15B 503M 2025-03
Align Technology USD 2.4B 90.41M 2025-03
AtriCure USD 251.48M 16.34M 2025-03
Avanos Medical USD 393.4M 79.2M 2024-12
Bausch Health Companies USD 5.73B 42M 2025-03
Baxter International USD 8.85B 11M 2024-12
Bayer EUR 34.44B 1.31B 2024-12
Becton, Dickinson and Co. USD 8.67B 7M 2025-03
Boston Scientific USD 6.92B 1.84B 2024-12
Cooper Companies USD 1.99B 35.5M 2025-01
Dentsply International USD 1.75B 175M 2024-12
Dexcom USD 4.55B 252.4M 2025-03
Edwards Lifesciences USD 6.29B 442.3M 2024-12
Globus Medical USD 2.18B 120.73M 2024-12
Haemonetics USD 1.01B 49.97M 2024-12
Hologic USD 3.21B 284.9M 2025-03
Insulet USD 1.89B 30.4M 2024-12
Integra LifeSciences USD 1.08B 17.84M 2024-12
Intuitive Surgical USD 11.88B 331.3M 2025-03
J&J USD 71.55B 15.66B 2025-03
Medtronic USD 22.51B 75M 2025-01
Merit Medical Systems USD 958.64M 34.86M 2025-03
Novartis USD 29.7B 1.56B 2024-12
ResMed USD 3.21B 372.24M 2025-03
STAAR Surgical USD 367.94M 29.17M 2024-12
Steris USD 1.9B 40.02M 2024-12
Stryker USD 13.02B 1.83B 2025-03
Tandem Diabetes Care USD 663.44M 61.06M 2025-03
Teleflex USD 1.54B 67.79M 2025-03
Zimmer Biomet Holdings USD 4.67B 192.5M 2024-12



Cooper Companies Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.